July 26, 2016 12:13 PM ET


Company Overview of Solace Pharmaceuticals (UK) Ltd.

Executive Profile

Eliot R. Forster Ph.D.

Chief Executive Officer, Solace Pharmaceuticals (UK) Ltd.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 7 different industries.

See Board Relationships


Dr. Eliot R. Forster, Ph.D. serves as Chief Executive Officer of Immunocore Limited. Dr. Forster served as the Chief Executive Officer of Creabilis Therapeutics S.r.l. since September 2010. Dr. Forster served as the Chief Executive Officer of Solace Pharmaceuticals Inc., since May 14, 2007. Dr. Forster served as the Chief Executive Officer at Solace Pharmaceuticals (UK) Ltd. He served as the Chief Executive Officer of Creabilis SA. He specializes in biotechnology and ...

Corporate Headquarters

6 Denne Hill Business Centre
Canterbury, Kent CT4 6HD

United Kingdom

Phone: --
Fax: --

Board Members Memberships

Non-Executive Director


University of Liverpool
University of Liverpool
Henley Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Solace Pharmaceuticals (UK) Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.